Intellectual Property Office
In the table below we provide you with information about applications we have received to amend the specification of a patent under sections 27 and 75 before the court and the Office. The table also includes information about when you need to file an opposition if you wish to oppose the application to amend.
Where amendments have been filed electronically, you can obtain full details by selecting the patent number. If you are the patent owner(s), you should check these details carefully and inform us if there are any problems. Where amendments have been filed in paper form only, the symbol * appears in the table after the patent number.
In the case of amendments filed under section 75 before the court and under section 27 at the Office, reasons for the amendments are also provided.
You can obtain reasons for the amendments and full details of any amendments filed in paper form by contacting Litigation Section (telephone: +44 (0)1633 814334).
Opposition procedures
Section 75 before the court
If you want to oppose an amendment filed under section 75 before the court, you need to file a notice of opposition at the court. In the notice you need to set out clearly your reasons for opposing the amendment. You need to send us a copy of the notice and send a copy to anyone involved in the court proceedings. You need to do this within 14 days of the advertisement on our web site of the application to amend.
Section 75 before the comptroller and section 27 amendments
If you want to oppose an amendment filed under section 75 before the comptroller or an amendment filed under section 27, you need to complete and send us:
- 2 copies of form 15 with the fee of 50. You will need to pay a further fee of 350 later
- 2 copies of a statement setting out fully the facts of your case and what you want us to do
Opposition table 2022
| Section | Patents Journal | Deadline for filing opposition | Patent number and title | International Classification | Proprietor, including court action number (if any) and address for service |
|---|---|---|---|---|---|
| 27 | 6946 6 July 2022 | 4 weeks | Capacitive power transmission cable | H01b | Enertechnics Holdings Limited |
| 75 Before the Court | 6945 29 June 2022 | 14 days | Endoscopic device for causing hemostasis | A61B | Boston Scientific Limited HP-2022-000007 Simmons & Simmons LLP Citypoint 1 Ropemaker Street London EC2Y 9SS |
| 75 Before the Court | 6945 29 June 2022 | 14 days | Processing transmission signals in radio transmitter | H04L | Nokia Technologies OY HP-2021-000023 Bird & Bird LLP 12 New Fetter Lane London EC4A 1JP |
| 75 Before the Court | 6945 29 June 2022 | 14 days | Wind turbine | F03D | Siemens Gamesa Renewable Energy A/S HP-2021-000011 Bristows LLP 100 Victoria Embankment London EC4Y 0DH |
| 75 Before the Court | 6944 22 June 2022 | 14 days | Flavouring composition concentrates | A23L | Soluble Technologies Group LLP IP-2021-000102 Shakespeare Martineau LLP Waterfront House Waterfront Plaza 35 Station Street Nottingham NG2 3DQ |
| 75 Before the Court | 6944 22 June 2022 | 14 days | Robot for transporting storage bins | B65G | Autostore Technology AS HP-2020-000035 Kirkland & Ellis International LLP 30 St Mary Axe London EC3A 8AF |
| 75 Before the Court | 6939 18 May 2022 | 14 days | Sealing device | E04B | Manthorpe Building Products Limited HP-2022-000004 Marks & Clerk Law LLP 15 Fetter Lane London EC4A 1BW |
| 27 | 6939 18 May 2022 | 4 weeks | A method and apparatus for preventing unwanted code execution | G06F | Datawing Limited |
| 27 | 6938 11 May 2022 | 4 weeks | Heat transfer compositions | C09K | Mexichem Fluor S.A. de C.V. |
| 75 Before the Court | 6936 27 April 2022 | 14 days | EP2676967 Methods of treating inflammatory and autoimmune diseases with natalizumab | C07K | Biogen MA Inc. HP-2021-000031 Powell Gilbert LLP 85 Fleet Street London EC4Y 1AE |
| 75 Before the Court | 6934 13 April 2022 | 14 days | EP3017811 Apixaban formulations | A61K | Bristol-Myers Squibb Holdings Ireland Unlimited Company & Pfizer Inc. HP-2020-000048 HP-2021-000009 Hogan Lovells International LLP Atlantic House Holborn Viaduct London EC1A 2FG |
| 75 Before the Court | 6934 13 April 2022 | 14 days | EP3251660 Apixaban formulations | A61K | Bristol-Myers Squibb Holdings Ireland Unlimited Company & Pfi
Related ArticlesCommentsWrite a CommentMinisterial Departmental News
News CalendarRecent CommentsFollow Us on TwitterTweets by @gov_wire |